|
1
|
Lu J, Getz G, Miska EA, Alvarez-Saavedra
E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA,
et al: MicroRNA expression profiles classify human cancers. Nature.
435:834–838. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yang LH, Dong Z and Gong ZH: Extracellular
miRNA: A novel molecular biomarker for lung cancer. Yi Chuan.
34:651–658. 2012.(In Chinese). View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Gao W, Lu X, Liu L, Xu J, Feng D and Shu
Y: MiRNA-21: A biomarker predictive for platinum-based adjuvant
chemotherapy response in patients with non-small cell lung cancer.
Cancer Biol Ther. 13:330–340. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ebert MS and Sharp PA: Roles for microRNAs
in conferring robustness to biological processes. Cell.
149:515–524. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bartel DP: MicroRNAs: Target recognition
and regulatory functions. Cell. 136:215–233. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bowen T, Jenkins RH and Fraser DJ:
MicroRNAs, transforming growth factor beta-1, and tissue fibrosis.
J Pathol. 229:274–285. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhou L, Liang X, Zhang L, Yang L, Nagao N,
Wu H, Liu C, Lin S, Cai G and Liu J: MiR-27a-3p functions as an
oncogene in gastric cancer by targeting BTG2. Oncotarget.
7:51943–51954. 2016.PubMed/NCBI
|
|
9
|
Guo D, Li Q, Lv Q, Wei Q, Cao S and Gu J:
MiR-27a targets sFRP1 in hFOB cells to regulate proliferation,
apoptosis and differentiation. PLoS One. 9:e913542014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Urbich C, Kaluza D, Frömel T, Knau A,
Bennewitz K, Boon RA, Bonauer A, Doebele C, Boeckel JN,
Hergenreider E, et al: MicroRNA-27a/b controls endothelial cell
repulsion and angiogenesis by targeting semaphorin 6A. Blood.
119:1607–1616. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Deng M, Tang H, Zhou Y, Zhou M, Xiong W,
Zheng Y, Ye Q, Zeng X, Liao Q, Guo X, et al: miR-216b suppresses
tumor growth and invasion by targeting KRAS in nasopharyngeal
carcinoma. J Cell Sci. 124:2997–3005. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Luo Z, Dai Y, Zhang L, Jiang C, Li Z, Yang
J, McCarthy JB, She X, Zhang W, Ma J, et al: miR-18a promotes
malignant progression by impairing microRNA biogenesis in
nasopharyngeal carcinoma. Carcinogenesis. 34:415–425. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Alajez NM, Lenarduzzi M, Ito E, Hui AB,
Shi W, Bruce J, Yue S, Huang SH, Xu W, Waldron J, et al: MiR-218
suppresses nasopharyngeal cancer progression through downregulation
of survivin and the SLIT2-ROBO1 pathway. Cancer Res. 71:2381–2391.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lu J, He ML, Wang L, Chen Y, Liu X, Dong
Q, Chen YC, Peng Y, Yao KT, Kung HF, et al: MiR-26a inhibits cell
growth and tumorigenesis of nasopharyngeal carcinoma through
repression of EZH2. Cancer Res. 71:225–233. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ji Y, He Y, Liu L and Chong X: MiRNA-26b
regulates the expression of cyclooxygenase-2 in
desferrioxamine-treated CNE cells. FEBS Lett. 584:961–967. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Li G, Wu Z, Peng Y, Liu X, Lu J, Wang L,
Pan Q, He ML and Li XP: MicroRNA-10b induced by Epstein-Barr
virus-encoded latent membrane protein-1 promotes the metastasis of
human nasopharyngeal carcinoma cells. Cancer Lett. 299:29–36. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wong TS, Man OY, Tsang CM, Tsao SW, Tsang
RK, Chan JY, Ho WK, Wei WI and To VS: MicroRNA let-7 suppresses
nasopharyngeal carcinoma cells proliferation through downregulating
c-Myc expression. J Cancer Res Clin Oncol. 137:415–422. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhang L, Deng T, Li X, Liu H, Zhou H, Ma
J, Wu M, Zhou M, Shen S, Li X, et al: microRNA-141 is involved in a
nasopharyngeal carcinoma-related genes network. Carcinogenesis.
31:559–566. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Xia H, Ng SS, Jiang S, Cheung WK, Sze J,
Bian XW, Kung HF and Lin MC: miR-200a-mediated downregulation of
ZEB2 and CTNNB1 differentially inhibits nasopharyngeal carcinoma
cell growth, migration and invasion. Biochem Biophys Res Commun.
391:535–541. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Gourzones C, Jimenez AS and Busson P:
Profiling of Epstein-Barr virus-encoded microRNAs in nasopharyngeal
carcinoma reveals potential biomarkers and oncomirs. Cancer.
118:4634author reply 4634. –4635. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Xie YJ, Long ZF and He XS: Involvement of
EBV-encoded BART-miRNAs and dysregulated cellular miRNAs in
nasopharyngeal carcinoma genesis. Asian Pac J Cancer Prev.
14:5637–5644. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Barth S, Meister G and Grässer FA:
EBV-encoded miRNAs. Biochim Biophys Acta. 1809:631–640. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wang F, Lu J, Peng X, Wang J, Liu X, Chen
X, Jiang Y, Li X and Zhang B: Integrated analysis of microRNA
regulatory network in nasopharyngeal carcinoma with deep
sequencing. J Exp Clin Cancer Res. 35:172016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Luo Z, Zhang L, Li Z, Li X, Li G, Yu H,
Jiang C, Dai Y, Guo X, Xiang J, et al: An in silico analysis of
dynamic changes in microRNA expression profiles in stepwise
development of nasopharyngeal carcinoma. BMC Med Genomics. 5:32012.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Cho JH, Gelinas R, Wang K, Etheridge A,
Piper MG, Batte K, Dakhallah D, Price J, Bornman D, Zhang S, et al:
Systems biology of interstitial lung diseases: Integration of mRNA
and microRNA expression changes. BMC Med Genomics. 4:82011.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zungu IL, Mbene AB, Evans Hawkins DH,
Houreld NN and Abrahamse H: Phototherapy promotes cell migration in
the presence of hydroxyurea. Lasers Med Sci. 24:144–150. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Tian Y, Fu S, Qiu GB, Xu ZM, Liu N, Zhang
XW, Chen S, Wang Y, Sun KL and Fu WN: MicroRNA-27a promotes
proliferation and suppresses apoptosis by targeting PLK2 in
laryngeal carcinoma. BMC Cancer. 14:6782014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Liu F, Zhang S, Zhao Z, Mao X, Huang J, Wu
Z, Zheng L and Wang Q: MicroRNA-27b up-regulated by human
papillomavirus 16 E7 promotes proliferation and suppresses
apoptosis by targeting polo-like kinase2 in cervical cancer.
Oncotarget. 7:19666–19679. 2016.PubMed/NCBI
|
|
29
|
Wu XZ, Wang KP, Song HJ, Xia JH, Jiang Y
and Wang YL: MiR-27a-3p promotes esophageal cancer cell
proliferation via F-box and WD repeat domain-containing 7 (FBXW7)
suppression. Int J Clin Exp Med. 8:15556–15562. 2015.PubMed/NCBI
|
|
30
|
Li Y, Li J, Sun X, Chen J, Sun X, Zheng J
and Chen R: MicroRNA-27a functions as a tumor suppressor in renal
cell carcinoma by targeting epidermal growth factor receptor. Oncol
Lett. 11:4217–4223. 2016.PubMed/NCBI
|
|
31
|
Zhao Y, Wang P, Meng J, Ji Y, Xu D, Chen
T, Fan R, Yu X, Yao J and Dong C: MicroRNA-27a-3p inhibits
melanogenesis in mouse skin melanocytes by targeting Wnt3a. Int J
Mol Sci. 16:10921–10933. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kunde SA, Rademacher N, Tzschach A,
Wiedersberg E, Ullmann R, Kalscheuer VM and Shoichet SA:
Characterisation of de novo MAPK10/JNK3 truncation mutations
associated with cognitive disorders in two unrelated patients. Hum
Genet. 132:461–471. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Yoo KH, Park YK, Kim HS, Jung WW and Chang
SG: Identification of MAPK10 as a novel epigenetic marker for
chromophobe kidney cancer. Pathol Int. 61:52–54. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Gourmaud S, Paquet C, Dumurgier J, Pace C,
Bouras C, Gray F, Laplanche JL, Meurs EF, Mouton-Liger F and Hugon
J: Increased levels of cerebrospinal fluid JNK3 associated with
amyloid pathology: Links to cognitive decline. J Psychiatry
Neurosci. 40:151–161. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Ying J, Li H, Cui Y, Wong AH, Langford C
and Tao Q: Epigenetic disruption of two proapoptotic genes
MAPK10/JNK3 and PTPN13/FAP-1 in multiple lymphomas
and carcinomas through hypermethylation of a common bidirectional
promoter. Leukemia. 20:1173–1175. 2006. View Article : Google Scholar : PubMed/NCBI
|
